The ADRD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ADRD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ADRD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ADRD Detailed Price Forecast - CNN Money||View ADRD Detailed Summary - Google Finance|
|View ADRD Detailed Summary - Yahoo! Finance||View ADRD Stock Research & Analysis - Zacks.com|
|View ADRD Trends & Analysis - Trade-Ideas||View ADRD Major Holders - Barrons|
|View ADRD Call Transcripts - NASDAQ||View ADRD Breaking News & Analysis - Seeking Alpha|
|View ADRD Annual Report - CompanySpotlight.com||View ADRD OTC Short Report - OTCShortReport.com|
|View ADRD Fundamentals - TradeKing||View ADRD SEC Filings - Bar Chart|
|View Historical Prices for ADRD - The WSJ||View Performance/Total Return for ADRD - Morningstar|
|View the Analyst Estimates for ADRD - MarketWatch||View the Earnings History for ADRD - CNBC|
|View the ADRD Earnings - StockMarketWatch||View ADRD Buy or Sell Recommendations - MacroAxis|
|View the ADRD Bullish Patterns - American Bulls||View ADRD Short Pain Metrics - ShortPainBot.com|
|View ADRD Stock Mentions - StockTwits||View ADRD Stock Mentions - PennyStockTweets|
|View ADRD Stock Mentions - Twitter||View ADRD Investment Forum News - Investor Hub|
|View ADRD Stock Mentions - Yahoo! Message Board||View ADRD Stock Mentions - Seeking Alpha|
|View Insider Transactions for ADRD - SECform4.com||View Insider Transactions for ADRD - Insider Cow|
|View ADRD Major Holdings Summary - CNBC||View Insider Disclosure for ADRD - OTC Markets|
|View Insider Transactions for ADRD - Yahoo! Finance||View Institutional Holdings for ADRD - NASDAQ|
|View ADRD Stock Insight & Charts - FinViz.com||View ADRD Investment Charts - StockCharts.com|
|View ADRD Stock Overview & Charts - BarChart||View ADRD User Generated Charts - Trading View|
Sanofi’s Q3 Earnings: Analysts’ Estimates
Posted on Tuesday October 30, 2018
Sanofi (SNY) is one of the largest pharmaceutical companies. Since the company’s headquarters are in Paris, its reports its financial results in euros. Sanofi is set to release its third-quarter earnings on October 31. Wall Street analysts expect the EPS to be 1.71 euros on revenues of 9.32 billion euros during the third quarter.
How Novartis’s Alcon Performed in Third Quarter
Posted on Tuesday October 23, 2018
Alcon, the eye care business of Novartis AG (NVS), includes surgical products and vision care products. Alcon reported revenues of ~$1.76 billion during the third quarter of 2018, a 3% increase in year-over-year (or YoY) revenues as compared to ~$1.71 billion in the third quarter of 2017. The growth was driven by a 5% growth in operating revenues, offset by a 2% negative impact of foreign exchange.
How Novartis’s Business Segments Performed in the Third Quarter
Posted on Monday October 22, 2018
As discussed earlier, Novartis (NVS) missed Wall Street analysts’ estimates for revenues with reported revenues of ~$12.78 billion during the third quarter of 2018, a 2.9% increase in YoY revenues. Novartis AG is the holding company providing healthcare solutions, and its business is classified into three business segments including the Innovative Medicines segment, Sandoz, and Alcon. The below chart shows the revenue performance of Novartis’s segments since the first quarter of 2017.
Analysts’ Estimates and Ratings for Novartis in October
Posted on Thursday October 11, 2018
Novartis’s (NVS) revenue is mainly driven by the strong performance of its Innovative Medicines segment, while Sandoz and Alcon also contribute to the company’s overall growth.